Prurigo pigmentosa is distinctive histopathologically

International Journal of Dermatology

Volumn 42, Issue 5, 2003, Pages 417-418

  Böer, Almut ^a   Ackerman, A Bernard ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b ACKERMAN ACADEMY OF DERMATOPATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; DOXYCYCLINE; MINOCYCLINE;

CLINICAL FEATURE; DRUG INHIBITION; DRUG RESPONSE; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; HYPERPLASIA; KERATOSIS; LETTER; NEUTROPHIL; PAPULE; PARAKERATOSIS; PRURIGO; SKIN ABSCESS; SKIN INFILTRATE; SKIN NECROSIS; SKIN PIGMENTATION;

EID: 0037866662     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01745.x     Document Type: Letter

References (8)

1. Harms M, Mérot Y, Polla L, Saurat JH. Prurigo pigmentosa: 3rd non-Japanese case. Dermatologica 1986; 173: 202-204.
2. Matsunaga J, Hattyoume N, Tagami Y. Prurigo pigmentosa with intraepidermal vesicles containing many dyskeratoticcells and neutrophils (in Japanese). Rinsho Derma (Tokyo) 1989; 31: 273-276.
3. Sakamoto T, Tokura Y, Tikigawa M. Prurigo pigmentosa, a case report with immunohistogical observations. Eur J Dermatol 1992; 2: 161-163.
4. Fujita Y, Kasuoka K, Arai A, Iwasaki M. Prurigo pigmentosa - Statistical examination of 23 cases based on the histological and immunohistochemical studies (in Japanese). Nishinihon Hifuka 1994; 56 (4): 749-757.
5. Böer A, Misago N, Wolter M, et al. Prurigo pigmentosa: New observations and comprehensive review. Dermatopathology: Practical and Conceptual 2002; 8 (3) (http://www.derm101.com).
6. Böer A, Misago N, Wolter M, et al. Prurigo pigmentosa: Elucidation of a distinctive inflammatory disease of the skin. Am J Dermatopathol 2002; 24 (5): 429.
7. Miyachi Y, Niwa Y. Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol 1982; 107: 209-214.
8. Elewski BE, Lamb BAJ, Sams WM, Gammon WR. In vivo supression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol 1983; 8 (6): 807-812.